跳至主要内容
临床试验/NCT03310801
NCT03310801已完成不适用

Comparison of Clinical Outcomes Between Left Atrial Appendage Occlusion With Dual Antiplatelet Therapy Versus Conventional Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-eluting Stent Implantation

Korea University Anam Hospital0 个研究点目标入组 480 人开始时间: 2016年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
480
主要终点
Composite of stroke and major bleeding

研究概览

简要总结

This study will retrospectively review and compare clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.

详细描述

Composite of stroke and major bleeding will be compared after adjusting those groups using inverse probability weighted model.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with AF who underwent PCI and treated with LAAO and DAPT or conventional antithrombotic therapy

排除标准

  • 未提供

结局指标

主要结局

Composite of stroke and major bleeding

时间窗: From date of index procedure until the date of primary endpoint occur or date of last follow up, whichever came first, assessed up to 50 months

Primary endpoint is a composite of stroke and major bleeding. Stroke is defined as ischemic cerebrovascular event included both transient ischemic attack and ischemic cerebral infarction. Major bleeding event was defined as moderate or severe bleeding according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries criteria.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Cheol Woong Yu

Professor

Korea University Anam Hospital

相似试验